FDA 483 - QPS, LLC - January 30, 2026

QPS, LLC, an analytical facility in Newark, DE, was inspected by the FDA, revealing two observations. The firm failed to adhere to its Standard Operating Procedures for sample analysis, specifically regarding repeated re-assays. Additionally, the firm maintained source records with discrepancies that prevented the complete reconstruction of method validation data.